NitecaponeAlternative Names: OR 462
Latest Information Update: 12 Sep 2003
At a glance
- Originator Orion
- Class Anti-ischaemics; Antihyperlipidaemics; Antiulcers; Catechols; Cytoprotectives; Pentanones; Small molecules
- Mechanism of Action Antioxidants; Catechol-O-methyltransferase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Atherosclerosis; Peptic ulcer; Reperfusion injury